QLH12016
Sponsors
Qilu Pharmaceutical Co., Ltd.
Conditions
Advanced Prostate CancerProstate CancerProstatic Neoplasms
Phase 1
Trial of QLH12016 in Patients With Metastatic Castration Resistant Prostate Cancer
NCT05973149
Start: 2023-08-31End: 2026-01-01Target: 108Updated: 2023-08-02
Study of QLH12016 in Combination With Novel Hormonal Agent in Subjects With Advanced Prostate Cancer
Not yet recruitingNCT07104110
Start: 2025-10-31End: 2028-10-31Target: 50Updated: 2025-08-05
A Clinical Study of QLC5508 and/or QLH12016 in Combination With Other Anti-tumor Therapies in Subjects With Advanced Prostate Cancer
Not yet recruitingNCT07198633
Start: 2025-10-31End: 2027-12-31Target: 212Updated: 2025-09-30